<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Leuprolide</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00007</strong>&#160; (BIOD00009, BTD00009)</td></tr><tr><th>Type</th><td>biotech</td></tr><tr><th>Groups</th><td>approved, investigational</td></tr><tr><th>Description</th><td><p>Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer&#8217;s disease.</p></td></tr><tr><th>Protein structure</th><td><a href="/system/protein_structures/full/DB00007.png?1330706510"><img alt="Db00007" src="/system/protein_structures/thumb/DB00007.png?1330706510"></a></td></tr><tr><th>Protein chemical formula</th><td>C<sub>59</sub>H<sub>84</sub>N<sub>16</sub>O<sub>12</sub></td></tr><tr><th>Protein average weight</th><td>1209.3983</td></tr><tr><th>Sequences</th><td><pre class="sequence">&gt;Leuprolide
PHWSYLLR</pre><small><a class="btn btn-info btn-sm" href="/drugs/DB00007/polypeptide_sequences.fasta">Download FASTA Format</a></small></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Leuprorelin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Leuprolide acetate</strong>
          <div class="cas">74381-53-6</div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000105/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000105/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: RGLRXNKKBLIBQS-XNHQSDQCSA-N</li>
              <li>Monoisotopic Mass: 1268.666591604</li>
              <li>Average Mass: 1269.4502</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000105">DBSALT000105</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Eligard</td><td>Atrix Labs/QLT Inc</td></tr><tr><td>Enantone</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Leuplin</td><td>Takeda</td></tr><tr><td>LeuProMaxx</td><td>Baxter/Teva</td></tr><tr><td>Leupromer</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Lupron</td><td>Abbott/TAP Pharmaceuticals</td></tr><tr><td>Lutrate</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Memryte</td><td>Curaxis</td></tr><tr><td>Prostap 3</td><td>Takeda UK</td></tr><tr><td>Prostap SR</td><td>Takeda UK</td></tr><tr><td>Viadur</td><td>Bayer AG</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/antineoplastic-agents-hormonal">Antineoplastic Agents, Hormonal</a></li>
<li><a href="/mesh/fertility-agents-female">Fertility Agents, Female</a></li>
<li><a href="/mesh/estrogen-antagonists">Estrogen Antagonists</a></li></ul></td></tr><tr><th>CAS number</th><td>53714-56-0</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organic Acids</td></tr><tr><th>Class</th><td>Carboxylic Acids and Derivatives</td></tr><tr><th>Subclass</th><td>Amino Acids, Peptides, and Analogues</td></tr><tr><th>Direct parent</th><td>Peptides</td></tr><tr><th>Alternative parents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Substituents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Classification description</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty</td></tr><tr><th>Pharmacodynamics</th><td>Used in the palliative treatment of advanced prostate cancer. Leuprolide is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis.</td></tr><tr><th>Mechanism of action</th><td>Leuprolide binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion.</td></tr><tr><th>Absorption</th><td>Bioavailability by subcutaneous administration is comparable to that by intravenous administration.</td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>27 L [intravenous bolus administration to healthy male volunteers]</li>
</ul></td></tr><tr><th>Protein binding</th><td>43% to 49%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Primarily degraded by peptidase and not by cytochrome P450 enzymes.</p></td></tr><tr><th>Route of elimination</th><td>Excretion in urine</td></tr><tr><th>Half life</th><td>~3 hours</td></tr><tr><th>Clearance</th><td><ul>
	<li>8.34 L/h [healthy male receiving a 1-mg IV bolus]</li>
</ul></td></tr><tr><th>Toxicity</th><td>In rats subcutaneous administration of 250 to 500 times the recommended human dose, expressed on a per body weight basis, resulted in dyspnea, decreased activity, and local irritation at the injection site. There is no evidence at present that there is a clinical counterpart of this phenomenon. In early clinical trials with leuprolide acetate doses as high as 20 mg/day for up to two years caused no adverse effects differing from those observed with the 1 mg/day dose.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.abbott.com">Abbott Laboratories Ltd.</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li>Eon Labs</li>
<li><a href="http://www.hospira.com">Hospira Inc.</a></li>
<li>Oso Biopharmaceuticals Manufacturing LLC</li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.sanofi-aventis.com">Sanofi-Aventis Inc.</a></li>
<li><a href="http://www.sunpharma.com">Sun Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.takeda.com">Takeda Pharmaceutical Co. Ltd.</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.tolmar.com">Tolmar Inc.</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Liquid</td><td>Subcutaneous</td><td></td></tr><tr><td>Suspension, extended release</td><td>Intramuscular</td><td></td></tr><tr><td>Suspension, extended release</td><td>Subcutaneous</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Eligard 45 mg syringe</td><td>2959.2USD</td><td>syringe</td></tr><tr><td>Eligard 30 mg syringe</td><td>1972.8USD</td><td>syringe</td></tr><tr><td>Eligard 22.5 mg syringe</td><td>1479.6USD</td><td>syringe</td></tr><tr><td>Lupron 2-wk 1 mg/0.2 ml kit</td><td>594.37USD</td><td>kit</td></tr><tr><td>Eligard 7.5 mg syringe</td><td>493.2USD</td><td>syringe</td></tr><tr><td>Leuprolide Acetate 1 mg/0.2ml Kit 2.8ml 2-Week Kit</td><td>400.74USD</td><td>box</td></tr><tr><td>Leuprolide 2wk 1 mg/0.2 ml kit</td><td>385.33USD</td><td>kit</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>liquid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>hydrophobicity</td><td>0.1</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></table></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Daniel Kadzimirzs, Gerhard Jas, Volker Autze, &#8220;Solution-Phase Synthesis of Leuprolide and Its Intermediates.&#8221; U.S. Patent US20090005535, issued January 01, 2009.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=20090005535&amp;tbm=pts" target="_blank">US20090005535 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li>Saleh FM, Niel T, Fishman MJ: Treatment of paraphilia in young adults with leuprolide acetate: a preliminary case report series. J Forensic Sci. 2004 Nov;49(6):1343-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15568711">Pubmed</a></li>
	<li>Geier MR, Geier DA: The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med Hypotheses. 2005;64(5):946-54. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15780490">Pubmed</a></li>
	<li>Doraiswamy PM, Xiong GL: Pharmacological strategies for the prevention of Alzheimer&#8217;s disease. Expert Opin Pharmacother. 2006 Jan;7(1):1-10. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16370917">Pubmed</a></li>
	<li>Sequence Information <a href="http://www.freepatentsonline.com/EP1790656.html">Link</a></li>
	<li><a href="http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20(General%20Monographs-%20L)/LUPRON%20DEPOT.html">RxMed</a></li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA450203" target="_blank">PA450203 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/eligard.htm" target="_blank">http://www.rxlist.com/cgi/generic/eligard.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/cdi/leuprolide.html" target="_blank">http://www.drugs.com/cdi/leuprolide.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Leuprolide" target="_blank">Leuprolide <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>L02AE02<ul class="atc-drug-tree"><li><a href="/atc/L#L">L &#8212; ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS</a></li><li><a href="/atc/L02#L02">L02 &#8212; ENDOCRINE THERAPY</a></li><li><a href="/atc/L02A#L02A">L02A &#8212; HORMONES AND RELATED AGENTS</a></li><li><a href="/atc/L02AE#L02AE">L02AE &#8212; Gonadotropin releasing hormone analogues</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>10:00.00</li></ul></td></tr><tr><th>PDB Entries</th><td><ul><li><a class="wishart-link-out" href="http://www.rcsb.org/pdb/explore.do?structureId=1YY2" target="_blank">1YY2 <span class="glyphicon glyphicon-new-window"> </span></a></li></ul></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB00007.pdf?1265922813">show</a>(477 KB)</td></tr><tr><th>MSDS</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>